Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines

We identified sex-based differences in immune responses to an HIV vaccine regimen, but they varied by immunologic assay. While vaccine recipients AFAB demonstrated higher ADCC responses, AMAB exhibited higher CD4+ T cell response rates. Future analyses should investigate whether vaccine factors such as platform, dosing and adjuvants contribute to sex-based differences in immunogenicity of experimental HIV vaccines.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-05-14
DOI
https://doi.org/10.3389/fimmu.2025.1557009
Citations
2
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
2.07
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines

Kelly E. Seaton, David C. Montefiori, Mookho Malahleha, Zoe Moodie et al.
2 citations
Frontiers in Immunology
HIV Research and Treatment
2.07
article

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines

Kelly E. Seaton, David C. Montefiori, Mookho Malahleha, Zoe Moodie, Srilatha Edupuganti, Brodie Daniels, Craig Innes, Nonhlanhla N. Mkhize, Georgia D. Tomaras, Marguerite Koutsoukos, Alison C. Roxby, Linda‐Gail Bekker, Cassie Grimsley Ackerley, Guido Ferrari, Fatima Laher, Nicole L. Yates, Chenchen Yu, Jack Heptinstall, Kathryn Therese Mngadi, Briana D. Furch, M. Juliana McElrath, Lynn Morris, Mary Allen, Stephen C. DeRosa
article en
2 citations

Abstract

We identified sex-based differences in immune responses to an HIV vaccine regimen, but they varied by immunologic assay. While vaccine recipients AFAB demonstrated higher ADCC responses, AMAB exhibited higher CD4+ T cell response rates. Future analyses should investigate whether vaccine factors such as platform, dosing and adjuvants contribute to sex-based differences in immunogenicity of experimental HIV vaccines.

Frontiers in ImmunologyVol. 16
National Health Laboratory Service (ZA), South African Medical Research Council (ZA), National Institutes of Health (US), Desmond Tutu HIV Foundation (ZA), Emory University (US), University of Cape Town (ZA), Fred Hutch Cancer Center (US), Aurum Institute (ZA), Duke Medical Center (US), National Institute of Allergy and Infectious Diseases (US), GlaxoSmithKline (Switzerland) (CH), Perinatal HIV Research Unit (ZA), Setshaba Research Centre (ZA)
Openalex Percentile: Top 14%
HIV Research and Treatment
2.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.